Compare · ONCR vs TMPM
ONCR vs TMPM
Side-by-side comparison of Oncorus Inc. (ONCR) and Turmeric Acquisition Corp. (TMPM): market cap, price performance, sector, and recent activity on the wire.
Summary
- ONCR operates in Health Care, while TMPM operates in Finance - the two are in different parts of the market.
- TMPM is the larger of the two at $123.9M, about 1.5x ONCR ($82.3M).
- Company
- Oncorus Inc.
- Turmeric Acquisition Corp.
- Price
- $0.12-10.15%
- $10.01+0.00%
- Market cap
- $82.3M
- $123.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Business Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
Oncorus Inc.
Oncorus, Inc., a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various cancers. It is also developing ONCR-GBM, a preclinical stage oHSV program for treating brain cancer through intratumoral injection; and synthetic viral immunotherapies based on Coxsackievirus A21 and Seneca Valley Virus. Oncorus, Inc. has a clinical trial collaboration and supply agreement with MSD International GmbH to evaluate the safety and tolerability of ONCR-177 combined with Merck's cancer immunotherapy KEYTRUDA in its Phase 1 clinical trial in patients with solid tumors. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Turmeric Acquisition Corp.
Turmeric Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is headquartered in Cambridge, Massachusetts. Turmeric Acquisition Corp. operates as a subsidiary of Turmeric Management, LLC.
Latest ONCR
- SEC Form DEFA14A filed by Oncorus Inc.
- SEC Form 15-12G filed by Oncorus Inc.
- SEC Form DEFA14A filed by Oncorus Inc.
- Oncorus Inc. filed SEC Form 8-K: Leadership Update, Other Events, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders
- SEC Form S-8 POS filed by Oncorus Inc.
- SEC Form S-8 POS filed by Oncorus Inc.
- SEC Form S-8 POS filed by Oncorus Inc.
- SEC Form S-8 POS filed by Oncorus Inc.
- SEC Form RW filed by Oncorus Inc.
- Oncorus Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Leadership Update
Latest TMPM
- SEC Form SC 13G/A filed by Turmeric Acquisition Corp. (Amendment)
- SEC Form SC 13G/A filed by Turmeric Acquisition Corp. (Amendment)
- SEC Form 15-12G filed by Turmeric Acquisition Corp.
- SEC Form 25-NSE filed by Turmeric Acquisition Corp.
- Turmeric Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Turmeric Acquisition Corp. Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination
- Turmeric Acquisition Corp. Will Redeem Its Public Shares and Will Not Consummate an Initial Business Combination
- SEC Form PRE 14A filed by Turmeric Acquisition Corp.
- SEC Form 10-K/A filed by Turmeric Acquisition Corp. (Amendment)
- Turmeric Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing